Immunization Grant Program
The Section 317 program provides funding for immunization operations and infrastructure necessary to implement a comprehensive immunization program at the federal, state, and local levels.
Of the $300 million in Recovery Act funds allocated to the Section 317 program, $250 million will help existing Section 317 grantees acquire and make recommended vaccines available by using $200 million of these funds to purchase vaccines that will be made available to states and territories. The remaining $50 million will be used to provide program operation grants and vaccine distribution funding that states and territories will use to deliver the vaccines and strengthen vaccination programs. Vaccines and Recovery Act resources will also be made available to special Section 317 programs in Chicago, Houston, New York City, Philadelphia and San Antonio.
An additional $18 million in grants will be used to provide support to Section 317 grantees that demonstrate innovative approaches to increase the number of Americans who receive the childhood vaccine series, zoster vaccine, and influenza vaccine, and for improving reimbursement practices. Applications to apply for these grants will be made available on grants.gov.
Nearly $32 million in Recovery Act funds will be used to increase information, communication and education and strengthen the evidence base for immunization. This will include activities to increase national public awareness and knowledge about the benefits and risks of vaccines and vaccine-preventable diseases. Funds will also help provide tools and education for health care providers and to monitor and assess the impact and safety of licensed vaccines routinely recommended for use in the United States to ensure that national vaccine policy is appropriate and effective.
For more information on Section 317 as well as information on vaccine-preventable diseases, go to http://www.cdc.gov/vaccines/
Recovery Act Implementation Plan